Two Day Common Technical Document Course - Regulatory and Technical Requirements for CMC Management (London, United Kingdom - December 4-5, 2018)

News provided by

Sep 27, 2018, 16:15 ET

DUBLIN, Sept 27, 2018 /PRNewswire/ --

The "Common Technical Document" conference has been added to ResearchAndMarkets.com's offering.

Project management/collection of critical documents for chemistry, manufacturing and control (CMC) for global registration (CTD) and incorporate quality by design within the CTD

This two-day course will provide you with a clear understanding of the regulatory and technical requirements for CMC management of your full and generic application in major markets of EU and USA. Furthermore, the course examines the requirements for global roll out of the document to ROW regions including, LATAM, ASEAN, MENA and CIS territories.

You will increase your ability to manage all aspects of development of the CMC applications after two days of intensive lectures, group work, and discussion session, covering everything you need to know about compiling the chemistry and pharmacy section of your generic dossier.

This course will cover the following topics:

Effective compilation of CTD and critical review of documentation
Quality by design, critical attributes and developing new product using the CQA pyramid model
Compiling and submitting Module 3 (CTD) of your registration dossier
Identifying the extent of content expected by EU and US regulators
Achieving the quickest turnaround of your submission
Managing the pharmaceutical development and quality aspects of your developments and registration dossier in Europe and US
Ensuring right first time development
Meeting the legal framework and guidelines for the CMC/quality part of the document, and links to GMP

Agenda:

Programme Day One

What is the CTD? The road map to Module 3 Understanding ICH

Assessing the impact of the harmonisation - ICH guidelines

Preparing the drug substance section of the application - US and EU

Analysing the needs for the section
How to submit information - Drug Master Files, Certificates of Suitability, other methods
European Submissions, CEP and ASMF requirements
Detailed information requirements for the section
Q11 explained - EU and US expectations of FMEA analysis
Development expectations and scale-up requirements
Specific examples on EU / US format and guidance

GMP for Active Substances

Examining GMP requirements and EU and US expectations, inspection timing and interactions and contractual obligations

Case study: Essential information from API suppliers

The case study will allow participants to identify and understand the essential data requirements from API suppliers for submission of generic applications

Examining the content of the sections concerning the drug product. Composition and development of the drug product

Defining the formulation
Identifying the data needs for the pharmaceutical development section, explaining QBD and FMEA requirements
Multiple examples of Development Report content - practical for table of contents and creation of QBD Pyramid

Programme Day Two

(All Module Sections include Example Sections for Writing)

Writing the section on manufacture of the drug product and process validation

Examining the content of the section: How much information to provide
Defining the difference between process development and validation and looking at validation expectations in today's environment
Examining the content of the section

Writing the sections on Excipients and Packaging Components

Control of the Excipients/Packaging Components
Examples of data expectations
Examining maintaining these sections

Writing the sections on control of the finished product and Case Study

Examining the content of the section
Control of the drug product
Examples of specifications for Multiple Product Types
Examples for Method Summaries

Writing the stability section

Examining the content of the section
Evaluation of stability data and the impact on shelf

The function and content of the Quality Overall Summary

Overview of the current approaches
What is the Expert Report: Practical involvement of the expert
QOS explained and compared with Expert Report
Detailed content of the QOS

Examining Global Roll-out of CTD - Module 3

Examining Change Control - Practical tips

Practical Exercise in Generic Development

Identifying 10 - stage plan for developments

For more information about this conference visit https://www.researchandmarkets.com/research/wczgj9/two_day_common?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets